News
EQS-News: Bardahl selects Intershop to unify global B2B commerce operations
EQS-News: Bardahl selects Intershop to unify global B2B commerce operations
EQS-News: From deal to discovery: Gold Hunter now focusing on Great Northern project after CAD 48 million success!
EQS-News: From deal to discovery: Gold Hunter now focusing on Great Northern project after CAD 48 million success!
EQS-News: JOST Werke SE: JOST determines number of new shares and placement price
EQS-News: JOST Werke SE: JOST determines number of new shares and placement price
EQS-News: Pentixapharm Receives FDA “Study May Proceed” Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program
EQS-News: Pentixapharm Receives FDA “Study May Proceed” Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program
Proposed US$ 100 million credit facility from KfW IPEX-Bank
Proposed US$ 100 million credit facility from KfW IPEX-Bank
EQS-News: BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
EQS-News: BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
EQS-News: EVN AG: Business development in the first quarter of 2025/26
EQS-News: EVN AG: Business development in the first quarter of 2025/26
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Leclanché Appoints Jens Emrich as Chief Financial Officer
Leclanché Appoints Jens Emrich as Chief Financial Officer
EQS-News: Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab)
EQS-News: Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab)
EQS-News: MAX Automation SE: Changes to the Supervisory Board and Managing Directorate
EQS-News: MAX Automation SE: Changes to the Supervisory Board and Managing Directorate
EQS-Adhoc: MAX Automation SE: Oliver Jaster appointed Managing Director
EQS-Adhoc: MAX Automation SE: Oliver Jaster appointed Managing Director
EQS-News: HENSOLDT extends CEO Oliver Dörre's contract until end of 2031
EQS-News: HENSOLDT extends CEO Oliver Dörre's contract until end of 2031
EQS-Adhoc: JOST Werke SE: JOST launches a cash capital increase
EQS-Adhoc: JOST Werke SE: JOST launches a cash capital increase
Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc
Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The